Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings

International Journal of Methods in Psychiatric Research

Volumn 21, Issue 2, 2012, Pages 134-148

  Large, Matthew M ^a   Smith, Glen ^b   Sara, Grant ^c,d   Paton, Michael B ^e   Kedzior, Karina Karolina ^f   Nielssen, Olav B ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Northside Clinic   (Australia)

^c Mental Health and Drug and Alcohol Office NSW Health   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e MACQUARIE UNIVERSITY   (Australia)

^f JACOBS UNIVERSITY BREMEN   (Germany)

Author keywords

Cannabis; Drug assay; Drug screening; Drug testing; Mental health; Meta analysis; Stimulants; Substance use

Indexed keywords

ADDICTION; ADULT; ARTICLE; CLASSIFICATION; CONFIDENCE INTERVAL; DRUG SCREENING; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MALE; MENTAL DISEASE; MENTAL HEALTH; META ANALYSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RISK; SELF REPORT; SENSITIVITY AND SPECIFICITY; STATISTICS;

ADULT; CONFIDENCE INTERVALS; DRUG EVALUATION, PRECLINICAL; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MENTAL HEALTH; ODDS RATIO; PSYCHIATRIC STATUS RATING SCALES; SELF REPORT; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS;

EID: 84862807147     PISSN: 10498931     EISSN: 15570657     Source Type: Journal    
DOI: 10.1002/mpr.1350     Document Type: Article

References (56)

1. Albanese M.J., Bartel R.L., Bruno R.F., Morgenbesser M.W., Schatzberg A.F. (1994) Comparison of measures used to determine substance abuse in an inpatient psychiatric population. The American Journal of Psychiatry, 151(7), 1077-1078.
2. American Psychiatric Association. (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR), Arlington, VA, American Psychiatric Press.
3. Andreasson S., Allebeck P., Engstrom A., Rydberg U. (1987) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet, 330(8574), 1483-1486.
4. Appleby L., Luchins D.J., Dyson V. (1995) Effects of mandatory drug screens on substance use diagnoses in a mental hospital population. The Journal of Nervous and Mental Disease, 183(3), 183-184.
5. Badawi N., Simonsen K.W., Steentoft A., Bernhoft I.M., Linnet K. (2009) Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS. Clincial Chemistry, 55(11), 2004-2018, DOI: 10.1373/clinchem.2008.122341
6. Barnaby B., Drummond C., McCloud A., Burns T., Omu N. (2003) Substance misuse in psychiatric inpatients: comparison of a screening questionnaire survey with case notes. British Medical Journal, 327(7418), 783-784, DOI: 10.1136/bmj.327.7418.783
7. Barnett J.H., Werners U., Secher S.M., Hill K.E., Brazil R., Masson K., Pernet D.E., Kirkbride J.B., Murray G.K., Bullmore E.T., Jones, P.B. (2007) Substance use in a population-based clinic sample of people with first-episode psychosis. The British Journal of Psychiatry, 190, 515-520, DOI: 10.1192/bjp.bp.106.024448
8. Bertolín-Guillén J.M. (1999) Sensitiveness and specificity of psychotropic drugs analysis for the diagnosis of mental disorders. Adicciones, 11, 107-113.
9. Bonsack C., Camus D., Kaufmann N., Aubert A.C., Besson J., Baumann P., Borgeat F., Gillet M., Eap C.B. (2006) Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening. Addictive Behaviors, 31(7), 1252-1258, DOI: 10.1016/j.addbeh.2005.08.008
10. Brady K., Casto S. (1989) Illicit substance use by acutely psychotic patients. The American Journal of Psychiatry, 146(10), 1349-1350.
11. Brady K., Casto S., Lydiard R.B., Malcolm R., Arana G. (1991) Substance abuse in an inpatient psychiatric sample. The American Journal of Drug and Alcohol Abuse, 17(4), 389-397, DOI: 10.3109/00952999109001598
12. Chung R.C., Large M.M., Starmer G.A., Tattam B.N., Paton M.B., Nielssen O.B. (2009) The reliability of reports of recent psychoactive substance use at the time of admission to an acute mental health unit. Journal of Dual Diagnosis, 5(3&4), 392-403, DOI: 10.1080/15504260903176039
13. Claassen C.A., Gilfillan S., Orsulak P., Carmody T.J., Battaglia J., Rush A.J. (1997) Substance use among patients with a psychotic disorder in a psychiatric emergency room. Psychiatric Services, 48(3), 353-358.
14. Covell N., Essock S. (2008) Utility of hair, urine, and self-report to monitor drug use in research studies including people with schizophrenia. Journal of Dual Diagnosis, 4(4), 335-343, DOI: 10.1080/15504260802084425
15. Crowley T., Chesluk D., Dilts S., Hart R. (1974) Drug and alcohol abuse among psychiatric admissions. Archives of General Psychiatry, 30(1), 13-20.
16. Curran G.M., Sullivan G., Williams K., Han X., Allee E., Kotrla K.J. (2008) The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study. BMC Emergency Medicine, 8, 17, DOI: 10.1186/1471-227X-8-17
17. de Beaurepaire R., Lukasiewicz M., Beauverie P., Castera S., Dagorne O., Espaze R., Falissard B., Giroult P., Houery M., Mahuzier G., Matheron I., Niel P., Padovani P., Poisson N., Richier J.P., Rocher J., Ruetsh O., Touzeau D., Visinoni A., Molimard R. (2007). Comparison of self-reports and biological measures for alcohol, tobacco, and illicit drugs consumption in psychiatric inpatients. European Psychiatry, 22(8), 540-548, DOI: 10.1016/j.eurpsy.2007.05.001
18. DeQuardo J.R., Carpenter C.F., Tandon R. (1994) Patterns of substance abuse in schizophrenia: nature and significance. Journal of Psychiatric Research, 28(3), 267-275.
19. Elangovan N., Berman S., Meinzer A., Gianelli P., Miller H., Longmore W. (1993) Substance abuse among patients presenting at an inner-city psychiatric emergency room. Hospital & Community Psychiatry, 44(8), 782-784.
20. Ellinwood E.H. Jr. (1968) Amphetamine psychosis. II. Theoretical implications. International Journal of Neuropsychiatry, 4(1), 45-54.
21. Fazel S., Langstrom N., Hjern A., Grann M., Lichtenstein P. (2009) Schizophrenia, substance abuse, and violent crime. Journal of the American Medical Association, 301(19), 2016-2023, DOI: 10.1001/jama.2009.675
22. Flovig J.C., Vaaler A.E., Morken G. (2009) Substance use at admission to an acute psychiatric department. Nordic Journal of Psychiatry, 63(2), 113-119, DOI: 10.1080/08039480802294787
23. Fowler I.L., Carr V.J., Carter N.T., Lewin T.J. (1998) Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin, 24(3), 443-455.
24. Fritch D., Blum K., Nonnemacher S., Haggerty B.J., Sullivan M.P., Cone E.J. (2009) Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass pectrometry. Journal of Analytic Toxicology, 33(9), 569-577.
25. Galletly C.A., Field C.D., Prior M. (1993) Urine drug screening of patients admitted to a state psychiatric hospital. Hospital & Community Psychiatry, 44(6), 587-589.
26. Gilfillan S., Claassen C.A., Orsulak P., Carmody T.J., Sweeney J.B., Battaglia J., Rush A.J. (1998) A comparison of psychotic and nonpsychotic substance users in the psychiatric emergency room. Psychiatric Services, 49(6), 825-828.
27. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on alcohol and related conditions. Archives of General Psychiatry, 61(8), 807-816.
28. Hall R.C., Popkin M.K., Devaul R., Stickney S.K. (1977) The effect of unrecognized drug abuse on diagnosis and therapeutic outcome. The American Journal of Drug and Alcohol Abuse, 4(4), 455-465.
29. Helseth V., Lykke-Enger T., Aamo T.O., Johnsen J. (2005) Drug screening among patients aged 17-40 admitted with psychosis. Tidsskrift for den Norske Lægeforening, 125(9), 1178-1180.
30. Jackson C.T., Covell N.H., Frisman L.K., Essock S.M. (2004) Validity of self-reported drug use among people with co-occurring mental health and substance use disorders. Journal of Dual Diagnosis, 1(1), 49-63, DOI: 10.1300/j374v01n01_05
31. Katz G., Durst R., Shufman E., Bar-Hamburger R., Grunhaus L. (2008) Substance abuse in hospitalized psychiatric patients. The Israel Medical Association Journal: IMAJ, 10(10), 672-675.
32. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., Jeste D.V. (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. The Journal of Clinical Psychiatry, 63(10), 892-909.
33. Lambert M.T., Griffith J.M., Hendrickse W. (1996) Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center. Psychiatric Services, 47, 1104-1107.
34. Ley A., Jeffery D., Ruiz J., McLaren S., Gillespie C. (2002) Underdetection of comorbid drug use at acute psychiatric admission. The Psychiatrist, 26, 248, DOI: 10.1192/pb.26.7.248
35. Mallin R., Slott K., Tumblin M., Hunter M. (2002) Detection of substance use disorders in patients presenting with depression. Substance Abuse, 23(2), 115-120, DOI: 10.1023/A:1015391323164
36. Mauri M.C., Volonteri L.S., De Gaspari I.F., Colasanti A., Brambilla M.A., Cerruti L. (2006) Substance abuse in first-episode schizophrenic patients: a retrospective study. Clinical Practice and Epidemology in Mental Health, 2, 4, DOI:10.1186/1745-0179-2-4
37. Modestin J., Nussbaumer C., Angst K., Scheidegger P., Hell D. (1997) Use of potentially abusive psychotropic substances in psychiatric inpatients. European Archives of Psychiatry and Clinical Neuroscience, 247(3), 146-153, DOI: 10.1007/BF03033068
38. Perkins D.O., Gu H., Weiden P.J., McEvoy J.P., Hamer R.M., Lieberman J.A. (2008) Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. The Journal of Clinical Psychiatry, 69(1), 106-113.
39. Perrone J., De Roos F., Jayaraman S., Hollander J.E. (2001) Drug screening versus history in detection of substance use in ED psychiatric patients. The American Journal of Emergency Medicine, 19(1), 49-51, DOI: 10.1053/ajem.2001.20003
40. Robinson A.E., Wolkind S.N. (1970) Amphetamine abuse amongst psychiatric in-patients. The use of gas chromatography. The British Journal of Psychiatry, 116, 643-644.
41. Rosenthal J.A. (1996) Qualitative descriptors of strength of association and effect size. Journal of Social Service Research, 21, 37-59, DOI: 10.1300/J079v21n04_02
42. Schiller M.J., Shumway M., Batki S.L. (2000) Utility of routine drug screening in a psychiatric emergency setting. Psychiatric Services, 51(4), 474-478.
43. Scott K.M., McGee M.A., Oakley Browne M.A., Wells J.E. (2006) Mental disorder comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey. The Australian and New Zealand Journal of Psychiatry, 40(10), 875-881, DOI: 10.1111/j.1440-1614.2006.01906.x
44. Selten J.P., Bosman I.J., de Boer D., Veen N.D., van der Graaf Y., Maes R.A., Kahn R.S. (2002) Hair analysis for cannabinoids and amphetamines in a psychosis incidence study. European Neuropsychopharmacology, 12(1), 27-30.
45. Sembhi S., Lee J.W. (1999) Cannabis use in psychotic patients. The Australian and New Zealand Journal of Psychiatry, 33, 529-532.
46. Serper M.R., Chou J.C., Allen M.H., Czobor P., Cancro R. (1999) Symptomatic overlap of cocaine intoxication and acute schizophrenia at emergency presentation. Schizophrenia Bulletin, 25(2), 387-394.
47. Shaner A., Khalsa M.E., Roberts L., Wilkins J., Anglin D., Hsieh S.C. (1993) Unrecognized cocaine use among schizophrenic patients. The American Journal of Psychiatry, 150, 758-762.
48. Swanson J.W., Swartz M.S., Van Dorn R.A., Elbogen E.B., Wagner H.R., Rosenheck R.A., Stroup T.S., McEvoy J.P., Lieberman J.A. (2006) A national study of violent behavior in persons with schizophrenia. Archives of General Psychiatry, 63(5), 490-499.
49. Swartz M.S., Swanson J.W., Hannon M.J. (2003) Detection of illicit substance use among persons with schizophrenia by radioimmunoassay of hair. Psychiatric Services, 54(6), 891-895.
50. Swartz M.S., Wagner H.R., Swanson J.W., Stroup T.S., McEvoy J.P., Canive J.M., Miller D.D., Reimherr F., McGee M., Khan A., Van Dorn R., Rosenheck R.A., Lieberman J.A. (2006) Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. The Journal of Nervous and Mental Disease, 194(3), 164-172, DOI: 10.1097/01.nmd.0000202575.79453.6e
51. Swatek R. (1984) Marijuana use: persistence and urinary elimination. Journal of Substance Abuse Treatment, 1(4), 265-270, DOI: 10.1016/0740-5472(84)90005-9
52. Teesson M., Slade T., Mills K. (2009) Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. The Australian and New Zealand Journal of Psychiatry, 43(7), 606-614, DOI: 10.1080/0004867090297090
53. Test M.A., Wallisch L.S., Allness D.J., Ripp K. (1989) Substance use in young adults with schizophrenic disorders. Schizophrenia Bulletin, 15(3), 465-476.
54. Wade D., Harrigan S., Edwards J., Burgess P.M., Whelan G., McGorry P.D. (2006) Substance misuse in first-episode psychosis: 15-month prospective follow-up study. The British Journal of Psychiatry, 189, 229-234, DOI: 10.1192/bjp.bp.105.017236
55. Wilkins J.N., Shaner A.L., Patterson M., Setoda D., Gorelick D. (1991) Discrepancies between patient report, clinical assessment, and urine analysis in psychiatric patients during inpatient admission. Psychopharmacology Bulletin, 27(2), 149-154.
56. World Health Organization (2010) International Classification of Diseases. [17 November 2010].